80 Participants Needed

Protein Intake for Obesity

(OPBIM Trial)

PI
Overseen ByPrincipal Investigator, PhD RD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Do I have to stop taking my current medications for the trial?

If you are taking prescription anti-seizure, antidepressant, or antipsychotic medications, you will need to stop taking them to participate in the trial.

What data supports the effectiveness of the treatment Ensure for obesity?

Research shows that higher-protein diets can help with weight loss and maintaining a healthy weight by improving metabolism and reducing appetite. Studies also indicate that protein-enriched meal replacements, like Ensure, do not negatively impact liver, kidney, or bone health, making them a safe option for weight management.12345

Is protein supplementation safe for human consumption?

Research indicates that protein supplements, including those with whey protein and leucine, are generally safe for human consumption. Studies have shown no significant adverse effects on health markers, and they can improve muscle mass and strength, especially in older adults and those on low-calorie diets.36789

How does the treatment Ensure differ from other treatments for obesity?

Ensure is unique because it provides a higher-protein diet option, which can help with weight management by improving metabolism and reducing appetite. This approach is different from other treatments that may not focus on protein intake to aid in weight loss and maintenance.18101112

What is the purpose of this trial?

This study will examine a potential relationship between family history of obesity, that is whether people with at least one parent who had obesity in adulthood compared to people with two parents who did not have obesity in adulthood, and the ability of protein intake to curb further intake of food.

Eligibility Criteria

This trial is for individuals with a family history of obesity, specifically those who have at least one parent who had obesity in adulthood. It aims to understand if protein intake can help control food consumption compared to people whose parents did not have obesity.

Inclusion Criteria

Weight stable for at least 3 months
BMI 20-40
My parents did not have obesity in adulthood, or one of them did.

Exclusion Criteria

I do not have any neurological disorders.
No current diagnosis or history of anorexia nervosa
Not currently breastfeeding
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Preload Testing

Participants receive two different preloads on separate days to assess the effect on food intake and brain activation

2 days
2 visits (in-person)

Brain Imaging and Food Consumption

Functional near infra-red spectroscopy (fNIR) is used to measure brain activation during food consumption, specifically pizza, to assess the satiation response to protein

1 day
1 visit (in-person)

Follow-up

Participants are monitored for any delayed effects of the preloads and brain imaging

4 weeks

Treatment Details

Interventions

  • Ensure
Trial Overview The study is testing the effects of consuming Ensure (a nutritional drink) versus water on food intake and brain responses related to appetite and satiety in participants with different family histories of obesity.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: PreloadsExperimental Treatment1 Intervention
Delivery of two different preloads to all participants, each preload tested on a separate day/participant, prior to consumption of pizza

Ensure is already approved in United States, European Union, Canada for the following indications:

πŸ‡ΊπŸ‡Έ
Approved in United States as Ensure for:
  • Nutritional deficiency
  • Weight loss
  • Recovering from illness or surgery
  • Low residue diets
  • Occasional meal replacement
  • Between meal snack
πŸ‡ͺπŸ‡Ί
Approved in European Union as Ensure for:
  • Nutritional deficiency
  • Weight loss
  • Recovering from illness or surgery
  • Low residue diets
  • Occasional meal replacement
  • Between meal snack
πŸ‡¨πŸ‡¦
Approved in Canada as Ensure for:
  • Nutritional deficiency
  • Weight loss
  • Recovering from illness or surgery
  • Low residue diets
  • Occasional meal replacement
  • Between meal snack

Find a Clinic Near You

Who Is Running the Clinical Trial?

Drexel University

Lead Sponsor

Trials
160
Recruited
48,600+

Findings from Research

Higher-protein diets (1.2 to 1.6 g protein per kg of body weight per day) have been shown to lead to greater weight loss, fat mass loss, and preservation of lean mass compared to lower-protein diets, based on several meta-analyses of short-term studies.
While short-term studies consistently show benefits of higher protein intake, longer-term studies yield mixed results, primarily due to dietary compliance; those who adhered to higher-protein diets experienced significant improvements in body weight and cardiometabolic risk factors.
The role of protein in weight loss and maintenance.Leidy, HJ., Clifton, PM., Astrup, A., et al.[2023]
In a study involving 100 obese participants over 30 years old, both high protein (HP) and standard protein (SP) meal replacements led to similar weight loss outcomes after one year, indicating that protein-enriched meal replacements are effective for weight management.
Importantly, the study found no adverse effects on liver function, renal function, or bone density after one year of using protein-enriched meal replacements, suggesting they are safe for long-term use in weight management programs.
Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial.Li, Z., Treyzon, L., Chen, S., et al.[2021]
In an 8-week study with 12 elderly participants, a meal replacement formula containing essential amino acids (EAAMR) led to a greater reduction in adipose tissue compared to a competitive meal replacement, despite both groups losing about 7% of their total body weight.
While EAAMR did not significantly preserve lean tissue, it was associated with an increase in the skeletal muscle fractional synthesis rate (FSR), suggesting that it may help maintain muscle protein turnover during caloric restriction.
Whey protein and essential amino acids promote the reduction of adipose tissue and increased muscle protein synthesis during caloric restriction-induced weight loss in elderly, obese individuals.Coker, RH., Miller, S., Schutzler, S., et al.[2022]

References

The role of protein in weight loss and maintenance. [2023]
Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial. [2021]
Whey protein and essential amino acids promote the reduction of adipose tissue and increased muscle protein synthesis during caloric restriction-induced weight loss in elderly, obese individuals. [2022]
Positive effect of protein-supplemented hospital food on protein intake in patients at nutritional risk: a randomised controlled trial. [2014]
Effects of 6 Months of Soy-Enriched High Protein Compared to Eucaloric Low Protein Snack Replacement on Appetite, Dietary Intake, and Body Composition in Normal-Weight Obese Women: A Randomized Controlled Trial. [2021]
Supplementing Breakfast with a Vitamin D and Leucine-Enriched Whey Protein Medical Nutrition Drink Enhances Postprandial Muscle Protein Synthesis and Muscle Mass in Healthy Older Men. [2023]
Efficacy and safety assessment of protein supplement - micronutrient fortification in promoting health and wellbeing in healthy adults - a randomized placebo-controlled trial. [2023]
Whey Protein, L-Leucine and Vitamin D Supplementation for Preserving Lean Mass during a Low-Calorie Diet in Sarcopenic Obese Women. [2022]
A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial. [2022]
Impact of whey protein supplementation in a weight-loss intervention in rural dwelling adults: A feasibility study. [2022]
11.Russia (Federation)pubmed.ncbi.nlm.nih.gov
[Experience in using the biologically active additive "miprovit" in the treatment of various metabolic diseases]. [2013]
12.United Statespubmed.ncbi.nlm.nih.gov
Intake of Animal Protein Blend Plus Carbohydrate Improves Body Composition With no Impact on Performance in Endurance Athletes. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceΒ·Privacy PolicyΒ·CookiesΒ·Security